Stryker (NYSE: SYK) CFO receives 11,974 options at $360.82

Rhea-AI Filing Summary

Stryker Corporation reported that its VP and Chief Financial Officer, Preston Wendell Wells, received an employee stock option grant. On February 4, 2026, he was granted 11,974 stock options with an exercise price of $360.82 per share under the Stryker Corporation 2011 Long-Term Incentive Plan.

The options vest in stages, becoming exercisable as to 20% on each of the first five anniversaries of the grant date, and are scheduled to expire on February 3, 2036. Following this grant, he beneficially owns 11,974 derivative securities directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wells Preston Wendell

Role VP, Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option granted 02/04/2026 (right to buy)	11,974	$0.00	--

Holdings After Transaction: Employee Stock Option granted 02/04/2026 (right to buy) — 11,974 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wells Preston Wendell

(Last) (First) (Middle)

1941 STRYKER WAY

(Street)

PORTAGE MI 49002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STRYKER CORP [ SYK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option granted 02/04/2026 (right to buy)	$360.82	02/04/2026		A		11,974		(1)	02/03/2036	Common Stock	11,974	$0	11,974	D

Explanation of Responses:

1. Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.

Remarks:

	/s/ Austin Y. Ke, attorney-in-fact for Preston Wendell Wells	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Stryker (SYK) report for CFO Preston Wendell Wells?

Stryker reported a stock option grant to CFO Preston Wendell Wells. On February 4, 2026, he received 11,974 employee stock options at an exercise price of $360.82 per share, issued under the Stryker Corporation 2011 Long-Term Incentive Plan as part of his compensation.

How many Stryker (SYK) stock options were granted to the CFO and at what price?

The CFO received 11,974 Stryker employee stock options at $360.82 per share. These options were granted on February 4, 2026, and represent derivative securities giving him the right to buy Stryker common stock at that fixed exercise price in the future.

What is the vesting schedule for the Stryker (SYK) CFO’s new stock options?

The stock options vest in five equal annual installments of 20% each. They become exercisable as to 20% on each of the first five anniversaries of the February 4, 2026 grant date, aligning long-term incentives with extended service at Stryker Corporation.

When do the Stryker (SYK) CFO’s newly granted stock options expire?

The CFO’s newly granted employee stock options expire on February 3, 2036. This provides a roughly ten-year window from the 2026 grant date during which, after vesting, he may choose to exercise the options at the fixed $360.82 exercise price.

How many derivative securities does the Stryker (SYK) CFO own after this option grant?

After the grant, the CFO beneficially owns 11,974 derivative securities. All of these relate to the employee stock options granted on February 4, 2026, which are held directly and subject to the specified vesting and expiration terms in the incentive plan.

Under which plan were the Stryker (SYK) CFO’s stock options granted and what type are they?

The options were granted under the Stryker Corporation 2011 Long-Term Incentive Plan. They are employee stock options, described as a right to buy Stryker common stock, with an exercise price of $360.82 and staged vesting over five years.